HKMPF
Price:
$26.9313
Market Cap:
$5.77B
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovasc...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-08-22
Stock Exchange
PNK
Ticker
HKMPF
According to Hikma Pharmaceuticals PLC’s latest financial reports and current stock price. The company's current PE Ratio is 16.73. This represents a change of 38.65% compared to the average of 12.07 of the last 4 quarters.
The mean historical PE Ratio of Hikma Pharmaceuticals PLC over the last ten years is 18.93. The current 16.73 PE Ratio has changed 8.74% with respect to the historical average. Over the past ten years (40 quarters), HKMPF's PE Ratio was at its highest in in the December 2022 quarter at 68.92. The PE Ratio was at its lowest in in the December 2017 quarter at -0.98.
Average
18.93
Median
18.76
Minimum
-4.26
Maximum
35.09
Discovering the peaks and valleys of Hikma Pharmaceuticals PLC PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 43.33%
Maximum Annual PE Ratio = 35.09
Minimum Annual Increase = -538.46%
Minimum Annual PE Ratio = -4.26
Year | PE Ratio | Change |
---|---|---|
2024 | 15.49 | -42.20% |
2023 | 26.79 | 20.03% |
2022 | 22.32 | 35.48% |
2021 | 16.48 | -12.49% |
2020 | 18.83 | 43.33% |
2019 | 13.14 | -29.68% |
2018 | 18.68 | -538.46% |
2017 | -4.26 | -112.14% |
2016 | 35.09 | 31.06% |
2015 | 26.77 | 21.95% |
The current PE Ratio of Hikma Pharmaceuticals PLC (HKMPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
21.53
5-year avg
19.98
10-year avg
18.93
Hikma Pharmaceuticals PLC’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hikma Pharmaceuticals PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hikma Pharmaceuticals PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hikma Pharmaceuticals PLC's PE Ratio?
How is the PE Ratio calculated for Hikma Pharmaceuticals PLC (HKMPF)?
What is the highest PE Ratio for Hikma Pharmaceuticals PLC (HKMPF)?
What is the 3-year average PE Ratio for Hikma Pharmaceuticals PLC (HKMPF)?
What is the 5-year average PE Ratio for Hikma Pharmaceuticals PLC (HKMPF)?
How does the current PE Ratio for Hikma Pharmaceuticals PLC (HKMPF) compare to its historical average?